Not for personal consumption
Theyve helped with all kinds of immune conditions, in part by reducing inflammation, and we know that is an issue in long COVID. Desperate for therapies that work, the long COVID community has already begun experimenting with microdosing GLP-1 drugs, with a post made one year ago on the social news site Reddit entitled Ozempic for Long Covid? reporting anecdotal evidence of the drug helping some improve their symptoms
This may occur due to factors such as dose level, calorie intake, metabolic adaptation, or reduced physical activity
This creates what I believe could become one of the most fascinating challenges for sensory science and product development
80: 53841 Ummenhofer B, Jawari D
I covered the trials and the mechanism here